Literature DB >> 24761622

[Action of Euphorbia humifusa effective fraction on membrane biosynthesis and the gene expression of proteases MEP and SUB of Trichophyton rubrum].

Zhi-Jian Li, Ming-Yue Zhao, Gulnar Dawuti, Silafu Aibai.   

Abstract

This study is to investigate the effect of Euphorbia humifusa effective fraction (EHEF) on the CYP51 enzyme activity, the lanosterol content and the MEP, SUB gene expression of Trichophyton rubrum. Trichophyton rubrum was treated by EHEF for 7 days at 26 degrees C. The activity of CYP51 enzyme of Trichophyton rubrum in the cell membrane was determined by using ELISA kit, and the lanosterol content was investigated by using high performance liquid chromatography (HPLC), and the MEP, SUB gene expression of Trichophyton rubrum was detected with the reverse transcription polymerase chain reaction (RT-PCR) method. Results showed that EHEF can decrease the membrane CYP51 enzyme activity, and it also can accumulate the fungal lanosterol in a dose-dependent manner, and it also can decrease the gene expression of MEP and SUB. The antifungal mechanism of EHEF may be related to the inhibition on CYP51 enzyme activity, and to the effects on fungal cell membrane ergosterol biosynthesis. It may also play an antifungal effect by inhibiting the MEP, SUB gene expression of fungal proteases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24761622

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  2 in total

1.  Cytochrome P450 Sterol 14 Alpha-Demethylase Gene SsCI72380 Is Required for Mating/Filamentation and Pathogenicity in Sporisorium scitamineum.

Authors:  Huizhong Li; Yichang Cai; Quanqing Deng; Han Bao; Jianwen Chen; Wankuan Shen
Journal:  Front Microbiol       Date:  2021-12-23       Impact factor: 5.640

2.  Ellagic Acid Inhibits Trichophyton rubrum Growth via Affecting Ergosterol Biosynthesis and Apoptotic Induction.

Authors:  Zhi-Jian Li; Amima Abula; Abudumijiti Abulizi; Chun Wang; Qin Dou; Youlidouzi Maimaiti; Abudoujilili Abudouaini; Shi-Xia Huo; Silafu Aibai
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-27       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.